Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) EBIT Margin (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported EBIT Margin of -53447.62% for FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) EBIT Margin (2009 - 2013) Analysis & Trends

Dating back to FY2009, Kazia Therapeutics' EBIT Margin record includes 15 fiscal years.

  • EBIT Margin has a five-year change of -52244.51 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the lowest annual EBIT Margin in data going back to FY2009.
  • According to Business Quant data, EBIT Margin came in at -1171.97% in FY2024 and -58.64% in FY2021 (+1144.47 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 24.35%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 36.01%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 30.74%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 29.12%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 35.79%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 41.71%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 32.98%
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -87.17%
Aug 30, 2013 -167.18%
Dec 31, 2012 -61.99%
Dec 31, 2011 1,187.45%
Dec 31, 2010 891.05%
Dec 31, 2009 -10.39%
API Access

Kazia Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY